Clinical endpoints are measured using various methods, depending on the type of endpoint. For overall survival, patient follow-up and death records are analyzed. Progression-free survival is assessed through regular imaging studies, such as CT scans or MRIs, to monitor for disease progression. Response rates are determined through imaging and clinical evaluations of tumor size and characteristics. Quality of life is measured using validated questionnaires and patient-reported outcome measures.
